Literature DB >> 28486726

Management of Interface Fluid Syndrome After LASIK by Descemet Membrane Endothelial Keratoplasty in a Patient With Fuchs' Corneal Endothelial Dystrophy.

Mehdi Shajari, Parviz Rafiezadeh, Ivana Pavlovic, Kate Barbara Kubiak, Thomas Kohnen, Ingo Schmack.   

Abstract

PURPOSE: To report a case of interface fluid syndrome after LASIK in a patient with Fuchs' corneal endothelial dystrophy treated with Descemet membrane endothelial keratoplasty (DMEK).
METHODS: Case report.
RESULTS: A 74-year-old patient presented with interface fluid syndrome and was treated with DMEK. Its complications in the form of partial graft detachment and cystoid macular edema were successfully managed by rebubbling and topical treatment, respectively. The treatment led to amelioration of both visual acuity and patient satisfaction. At the examination 6 months after DMEK, the cornea was clear and corrected distance visual acuity improved to a satisfactory level.
CONCLUSIONS: Interface fluid syndrome can develop many years after LASIK as a result of corneal endothelial decompensation and can be effectively treated with DMEK. Close postoperative monitoring of patients is paramount to intervene therapeutically in case of transplant detachment or development of cystoid macular edema requiring further surgical or conservative management. [J Refract Surg. 2017;33(5):347-350.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Year:  2017        PMID: 28486726     DOI: 10.3928/1081597X-20170210-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  DMEK for the treatment of interface fluid syndrome secondary to failed DSAEK graft: A case report and review of the literature.

Authors:  Nuno Moura-Coelho; Elena Arrondo; Mario Renato Papa-Vettorazzi; João Paulo Cunha; José Luis Güell
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-10

2.  Interface fluid syndrome: A potential lifelong complication after LASIK. A case report.

Authors:  Zhe Jia; Shaozhen Zhao; Ruihua Wei; Yue Huang; Chen Zhang; Ruibo Yang
Journal:  Am J Ophthalmol Case Rep       Date:  2018-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.